NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
43 hedge funds and large institutions have $117M invested in NKGen Biotech, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.85M | |
| 2 | +$3.88M | |
| 3 | +$2.69M | |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$1.94M |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$1.84M |
Top Sellers
| 1 | -$3.41M | |
| 2 | -$2.47M | |
| 3 | -$1.45M | |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$836K |
| 5 |
EAM
Exos Asset Management
New York
|
-$678K |